Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




HbA1C Tests Performed on Analyzer in Community Healthcare Settings

By LabMedica International staff writers
Posted on 11 Dec 2009
A rapid analyzer allows on-the-spot blood testing for HbA1C, eliminating the need to send samples to the laboratory. More...


Suitable for clinics, pharmacies, and GP practices, the simple and economical test requires one drop of blood from a finger prick sample and delivers laboratory-quality results in less than four minutes.

Quotient Diagnostics (Walton on Thames, UK) developed the rapid, economical analyzer that allows HbA1c tests to be performed in community healthcare settings. With a small footprint and low weight, the analyzer, called Quo-Test, fits into the smallest space, and it can be easily moved to other sites. Compact, convenient, and easy to use, it calibrates automatically and can download results or print them onto a sticky label.

Quo-Test A1C is traceable to the International Federation of Clinical Chemistry (IFCC) reference method and has been certified by the National Glycohemoglobin Standardization Program (NGSP).

A report published by Diabetes UK warned that in the UK alone, nearly 800,000 people with diabetes are failing to adequately manage their blood glucose levels, putting themselves at risk of serious health problems such as blindness, heart disease, amputation and kidney failure.

The report emphasizes that maintaining HbA1c levels within the recommended range is the foundation of good diabetes management and that regular testing plays a crucial role in helping diabetics to control their condition and reduce the long-term health risks.

Quotient Diagnostics developed the rapid, convenient, and economical analyzer in response to this report.

Related Links:
Quotient Diagnostics


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Manual Pipetting Aid
Pipette Controllers macro
Gold Member
Aspiration System
VACUSAFE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.